• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于gyrA基因突变导致粘质沙雷氏菌自发喹诺酮耐药。

Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

作者信息

Masecar B L, Robillard N J

机构信息

Pharmaceutical Division, Miles Inc., West Haven, Connecticut 06516.

出版信息

Antimicrob Agents Chemother. 1991 May;35(5):898-902. doi: 10.1128/AAC.35.5.898.

DOI:10.1128/AAC.35.5.898
PMID:1649573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC245126/
Abstract

Spontaneous quinolone-resistant mutants of MP050, a quinolone-susceptible clinical strain of Serratia marcescens, were isolated on nutrient agar containing 0.5 microgram of ciprofloxacin per ml. One mutant, designated MP051, was selected for further study. Quinolone MICs for MP051 were 4- to 16-fold higher than those for MP050; nonquinolone MICs were unchanged. The DNA gyrase isolated from MP051 was 24-fold less sensitive to inhibition of supercoiling by ciprofloxacin than the DNA gyrase isolated from MP050 was. Inhibition studies on reconstituted combinations of heterologous gyrase subunits showed that the decreased inhibition was dependent on the A subunit of DNA gyrase from MP051. Further evidence that this decreased inhibition was due to a gyrA mutation was provided by analysis of Escherichia coli gyrA gene expression in S. marcescens heterodiploids containing pNJR3-2, a broad-host-range gyrA gene probe. Quinolone susceptibilities of MP051 heterodiploids containing the wild-type E. coli gyrA gene decreased to those of MP050, while quinolone susceptibilities of MP050 containing the same plasmid were unchanged. These results indicate that spontaneous quinolone resistance in MP051 was due to a mutation in gyrA.

摘要

从一株对喹诺酮敏感的粘质沙雷氏菌临床菌株MP050中,在每毫升含0.5微克环丙沙星的营养琼脂上分离出了自发的喹诺酮抗性突变体。选择了一个名为MP051的突变体进行进一步研究。MP051的喹诺酮最低抑菌浓度(MIC)比MP050高4至16倍;非喹诺酮类药物的MIC没有变化。从MP051中分离出的DNA促旋酶对环丙沙星抑制超螺旋的敏感性比从MP050中分离出的DNA促旋酶低24倍。对异源促旋酶亚基重组组合的抑制研究表明,抑制作用的降低取决于MP051的DNA促旋酶A亚基。通过分析含有广泛宿主范围的gyrA基因探针pNJR3-2的粘质沙雷氏菌异源二倍体中大肠杆菌gyrA基因的表达,进一步证明了这种抑制作用的降低是由于gyrA突变所致。含有野生型大肠杆菌gyrA基因的MP051异源二倍体的喹诺酮敏感性降至MP050的水平,而含有相同质粒的MP050的喹诺酮敏感性没有变化。这些结果表明,MP051中的自发喹诺酮抗性是由于gyrA突变引起的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd11/245126/3b95aeba91dd/aac00050-0144-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd11/245126/3b95aeba91dd/aac00050-0144-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd11/245126/3b95aeba91dd/aac00050-0144-a.jpg

相似文献

1
Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.由于gyrA基因突变导致粘质沙雷氏菌自发喹诺酮耐药。
Antimicrob Agents Chemother. 1991 May;35(5):898-902. doi: 10.1128/AAC.35.5.898.
2
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.粘质沙雷氏菌DNA促旋酶gyrA基因的克隆、核苷酸序列分析及喹诺酮耐药临床分离株gyrA基因突变特征
Antimicrob Agents Chemother. 1998 Jan;42(1):190-3. doi: 10.1128/AAC.42.1.190.
3
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.环丙沙星与氟喹诺酮类药物。作用机制与耐药性的新概念
Am J Med. 1989 Nov 30;87(5A):2S-8S. doi: 10.1016/0002-9343(89)90010-7.
4
Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.阴沟肠杆菌喹诺酮耐药临床分离株中gyrA和parC基因突变的检测
J Antimicrob Chemother. 1997 Oct;40(4):543-9. doi: 10.1093/jac/40.4.543.
5
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.从野生型、gyrA型和多重耐药(marA)型菌株中筛选出的肠杆菌科喹诺酮耐药突变体的表型特征。
J Antimicrob Chemother. 1991 Aug;28(2):185-98. doi: 10.1093/jac/28.2.185.
6
Evidence of an efflux pump in Serratia marcescens.
Microb Drug Resist. 2000 Summer;6(2):111-7. doi: 10.1089/107662900419410.
7
New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.对DNA超螺旋具有分级效应的新型大肠杆菌gyrA和gyrB突变
Mol Gen Genet. 1989 Oct;219(1-2):306-12. doi: 10.1007/BF00261192.
8
Broad-host-range gyrase A gene probe.广宿主范围的gyrase A基因探针。
Antimicrob Agents Chemother. 1990 Oct;34(10):1889-94. doi: 10.1128/AAC.34.10.1889.
9
A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.大肠杆菌DNA促旋酶A中的一种新型双突变赋予对喹诺酮类抗生素的抗性。
Antimicrob Agents Chemother. 1997 Jan;41(1):85-90. doi: 10.1128/AAC.41.1.85.
10
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.gyrA和parC突变对大肠杆菌喹诺酮耐药性、倍增时间和超螺旋程度的影响。
Antimicrob Agents Chemother. 1999 Apr;43(4):868-75. doi: 10.1128/AAC.43.4.868.

引用本文的文献

1
Serratia infections: from military experiments to current practice.沙雷氏菌感染:从军事实验到当前实践。
Clin Microbiol Rev. 2011 Oct;24(4):755-91. doi: 10.1128/CMR.00017-11.
2
Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.粘质沙雷氏菌DNA促旋酶gyrA基因的克隆、核苷酸序列分析及喹诺酮耐药临床分离株gyrA基因突变特征
Antimicrob Agents Chemother. 1998 Jan;42(1):190-3. doi: 10.1128/AAC.42.1.190.
3
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.

本文引用的文献

1
In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.一株粘质沙雷氏菌对β-内酰胺类和氨基糖苷类抗生素同时产生体内和体外耐药性的情况。
Ann Microbiol (Paris). 1983 May-Jun;134A(3):329-37.
2
Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.一株对阿米卡星、头孢噻肟和拉莫三嗪耐药的粘质沙雷氏菌“灰色”菌落变体的质粒非依赖性耐药性
Chemotherapy. 1983;29(4):265-74. doi: 10.1159/000238208.
3
DNA gyrase: affinity chromatography on novobiocin-Sepharose and catalytic properties.
急诊室中的急性细菌性腹泻:粪便培养结果的治疗意义
J Accid Emerg Med. 1994 Sep;11(3):168-71. doi: 10.1136/emj.11.3.168.
4
Mechanisms of resistance to quinolones.喹诺酮类药物的耐药机制。
Drugs. 1993;45 Suppl 3:15-23. doi: 10.2165/00003495-199300453-00005.
5
In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.对五种喹诺酮类药物的体外研究:随着喹诺酮类耐药性上升,相对效力变化的证据。
Antimicrob Agents Chemother. 1991 Nov;35(11):2329-34. doi: 10.1128/AAC.35.11.2329.
DNA 回旋酶:新生霉素 - 琼脂糖亲和层析及催化特性
Nucleic Acids Res. 1981 Aug 11;9(15):3589-603. doi: 10.1093/nar/9.15.3589.
4
DNA gyrase subunit stoichiometry and the covalent attachment of subunit A to DNA during DNA cleavage.DNA 回旋酶亚基化学计量以及DNA切割过程中亚基A与DNA的共价连接。
Nucleic Acids Res. 1980 Sep 11;8(17):3865-74. doi: 10.1093/nar/8.17.3865.
5
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星(拜耳o 9867)的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
6
Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins.大肠杆菌DNA旋转酶A和B蛋白的克隆及简化纯化
J Biol Chem. 1984 Jul 25;259(14):9199-201.
7
Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation event.超螺旋脱氧核糖核酸-蛋白质松弛复合体的性质及松弛事件的链特异性
Biochemistry. 1970 Oct 27;9(22):4428-40. doi: 10.1021/bi00824a026.
8
Comparisons of F factors and R factors: existence of independent regulation groups in F factors.F 因子与 R 因子的比较:F 因子中独立调控基团的存在
J Bacteriol. 1970 Jul;103(1):81-8. doi: 10.1128/jb.103.1.81-88.1970.
9
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.耐萘啶酸的大肠杆菌K-12突变体:基因定位与显性研究。
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
10
Elimination of plasmids by new 4-quinolones.新型4-喹诺酮类药物对质粒的消除作用
Antimicrob Agents Chemother. 1985 Nov;28(5):700-2. doi: 10.1128/AAC.28.5.700.